Delivery Order SPE2DB22D2206-SPE2DB25FHF47
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,479.64 for GRALISE ER 300 mg tablets (90-count) with a firm fixed price contract type. The award was made on December 17, 2025, with an ultimate completion date of December 18, 2025, and represents a non-set-aside competitive award. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Gralise ER 600 mg tablets. The contract has a ceiling value of $1,029.03 and a period of performance through April 4, 2025. The contract is a firm-fixed price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $14,657.33 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation for the supply of GRALISE ER 600 MG tablets. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of GRALISE ER 300 mg tablets. The $2,861.65 firm-fixed-price contract has an ultimate completion date of August 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription medications to support military treatment facilities and federal healthcare programs. This award is part of a larger Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,578.64 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GRALISE ER 300 MG TABLET 90S. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
- The Defense Logistics Agency awarded a $1,173 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561327240 GRALISE ER 300 MG tablets. Under this order, Amerisourcebergen will deliver 90 tablets to a location in Conshohocken, Pennsylvania by June 26th to support the Department of Defense's medical supply needs. As a leading pharmaceutical distributor, Amerisourcebergen routinely fulfills delivery orders from the Defense Logistics Agency's prime vendor contracts to stock...
- This is a $8,879.52 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product, with a performance period ending on May 13, 2025. Amerisourcebergen Drug Corp is a for-profit organization and a critical supplier of medical and pharmaceutical products to federal agencies, particularly the military healthcare...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,519.89, is for the supply of Gralise ER 600 mg tablets. The contract has a firm fixed price and an ultimate completion date of February 7, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency Troop Support Medical awarded a $3,445.85 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561490969 GRALISE ER 600 MG TABLET 90S. The place of performance is Conshohocken, Pennsylvania. The period of performance is July 13, 2023 through July 14, 2023. No additional details were provided regarding the original solicitation or a larger vehicle. The award is made directly to Amerisourcebergen Drug Corporation as the prime contractor to...
- The Defense Logistics Agency awarded a $3,847.94 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561375571 GRALISE ER 600 MG TABLET 90S. The prime contractor Amerisourcebergen Drug Corporation, located in Conshohocken, Pennsylvania, will deliver the specified pharmaceutical product to the Defense Logistics Agency. The delivery order has a one day period of performance from June 29, 2023 to June 30, 2023. No additional details were provided regarding major...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHF47Delivery Order
The Defense Logistics Agency awarded a $7,157.24 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Gralise ER 300 mg tablets (90-count units). This contract represents a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The delivery order fulfills federal medical procurement needs for military and veteran healthcare systems, consistent with AmerisourceBergen's role as a critical pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 6/2/25 |